日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Stereotactic body radiation therapy combined with cadonilimab and lenvatinib in the treatment of hepatocellular carcinoma with Vp3 or Vp4 portal vein tumor thrombus: a prospective, multicenter, single-arm, phase II clinical trial

立体定向放射治疗联合卡多尼利单抗和乐伐替尼治疗伴有Vp3或Vp4门静脉癌栓的肝细胞癌:一项前瞻性、多中心、单臂II期临床试验

Mo, Ning; Hu, Kai; Zeng, Zhiming; Yang, Lihua; Fang, Yeying; Zeng, Jie; Li, Ye; Yang, Zhendong; Tang, Jing; Zhang, Tingting; Ma, Fuchao; Liu, Cuizhen; Zheng, Haiping; Qiu, Jinfeng; Jiang, Yanfeng; Lv, Yufeng; Liang, Li; Huang, Xiaofang; Liao, Xiwen; Wang, Yan; Lu, Xiuyuan; Ning, Lijun; Lao Guo, Shixue; Ma, Jie; Wang, Rensheng

Case Report: Pathologic complete response to PRaG therapy in an elderly patient with refractory metastatic gastric cancer

病例报告:老年难治性转移性胃癌患者接受PRaG治疗后病理完全缓解

Lv, Jun; Yu, Fayi; Pan, Linjiang; Fang, Yeying; Zhong, Zhenghong; Bai, Xue; Gao, Jinbiao; Wei, Zhuxin

YTHDF2 alleviates the radioresistance of rectal cancer cells by targeting methylated MYC.

YTHDF2 通过靶向甲基化的 MYC 来减轻直肠癌细胞的放射抗性。

Fang Yeying, Shang Shijie, Chen Gang, Chen Dawei, Yu Jinming

Prognostic value of peripheral blood fibrinogen-to-albumin ratio and neutrophil-to-lymphocyte ratio in patients with locally advanced or metastatic pancreatic cancer

外周血纤维蛋白原/白蛋白比值和中性粒细胞/淋巴细胞比值在局部晚期或转移性胰腺癌患者中的预后价值

Cheng, Hao; Lu, Dingyu; Yin, Chuou; Fang, Yeying

Elevated Expression of Inhibitor of Apoptosis-stimulating Protein of p53 (iASPP) and Methyltransferase-like 3 (METTL3) Correlate with Poor Prognosis in FIGO Ib1-IIa Squamous Cell Cervical Cancer

p53凋亡刺激蛋白抑制因子(iASPP)和甲基转移酶样3(METTL3)的高表达与FIGO Ib1-IIa期宫颈鳞状细胞癌预后不良相关

Wu, Fang; Zhang, Yong; Fang, Yeying; Ma, Shanshan; Zheng, Hua; Liu, Kang; Wang, Rensheng